Tremelimumab-actl
Generic Name: tremelimumab-actl
Manufactured by ASTRAZENECA AB. Dosage form: INJECTABLE. Route: INTRAVENOUS. Active ingredients: TREMELIMUMAB-ACTL (300MG/15ML(20MG/ML)). Application: BLA761270.
Overview
Manufactured by ASTRAZENECA AB. Dosage form: INJECTABLE. Route: INTRAVENOUS. Active ingredients: TREMELIMUMAB-ACTL (300MG/15ML(20MG/ML)). Application: BLA761270.
Dosage
Available as injectable for intravenous use.
Related Medications
Inclisiran
inclisiran
11 DESCRIPTION LEQVIO contains inclisiran sodium, a small interfering RNA (siRNA) directed to proprotein convertase subtilisin kexin type 9 (PCSK9) mRNA. Inclisiran contains a covalently linked ligand containing three N-acetylgalactosamine (GalNAc) residues to facilitate delivery to hepatocytes. With one exception, the 2'ribose moieties of the inclisiran sodium are present as 2'-F or 2'-OMe ribonucleotide.
Chamaelirium Luteum Root
chamaelirium luteum root
Vaginal itching and discomfort*
Ombitasvir, Paritaprevir, Ritonavir
ombitasvir, paritaprevir, ritonavir
Manufactured by ABBVIE. Dosage form: TABLET. Route: ORAL. Active ingredients: DASABUVIR SODIUM (EQ 250MG BASE); OMBITASVIR, PARITAPREVIR, RITONAVIR (12.5MG, 75MG, 50MG). Application: NDA206619.
Medical Disclaimer
This drug information is for educational purposes only and should not replace professional medical advice. Drug information is sourced from the FDA National Drug Code Directory and Structured Product Labeling. Always consult with a healthcare provider before starting, stopping, or changing any medication.